[Endothelial cells and vascular hemostasis].
Procoagulant, anticoagulant, and fibrinolytic activities are associated with endothelial cells and involve the production, secretion, and receptor mediated binding of proteins involved in these processes. The procoagulant aspect of endothelial cells function involves the production and release of von Willebrand Factor(vWF), the production of tissue factor, and the presence of Factor IX/IXa receptors on the cell surface. Secretion of vWf will promote the initial steps in thrombus formation by supporting platelet-platelet interaction and platelet-subendothelial matrix adhesion. Tissue factor which is undetectable in resting cells appears after exposure to various cytokines and initiates factor VIIa activation of factors IX and X. Receptors of Factor IX/IXa are also present and mediate the assembly of the prothrombinase complex on the endothelial cell surface. The anticoagulant pathway involves the cell surface protein thrombomodulin, protein C and its cofactor protein S. Thrombomodulin binds thrombin which activates protein C which in the presence of protein S cleaves and inactivates Factors V and VIII. Inactivation of these two coagulation cofactors halts the coagulation. Finally, endothelial cells also play a pivotal role in the fibrinolytic system. Production and regulated secretion of tissue plasminogen activator creates a profibrinolytic state in the endothelial cell environment. In addition, receptors for plasminogen and urokinase are also present, constituting a cell surface mediated fibrinolytic pathway. Plasminogen activator inhibitor type I, the primary inhibitor of tPA, is also produced by endothelial cells. Thus endothelial cells can promote and inhibit fibrinolysis, depending on the prevailing environmental conditions.
Levin
E G
EG
Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation.
Hanano
M
M
D016207:Cytokines / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000502:physiology*; D005164:Factor IX / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D005342:Fibrinolysis; D006023:Glycoproteins / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D010960:Plasminogen Activators / Q000378:metabolism; D015849:Plasminogen Inactivators / Q000378:metabolism; D011486:Protein C / Q000378:metabolism; D017293:Protein S; D011956:Receptors, Cell Surface / Q000378:metabolism; D018179:Receptors, Thrombin; D055293:Receptors, Urokinase Plasminogen Activator; D013925:Thromboplastin / Q000378:metabolism; D014841:von Willebrand Factor / Q000378:metabolism
D016207:Cytokines; D006023:Glycoproteins; C524898:PLAUR protein, human; D015849:Plasminogen Inactivators; D011486:Protein C; D017293:Protein S; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D055293:Receptors, Urokinase Plasminogen Activator; D014841:von Willebrand Factor; D005164:Factor IX; D005170:Factor X; D013925:Thromboplastin; D010960:Plasminogen Activators